Balloon Catheter

This channel includes news and new technology innovations for angioplasty balloon catheters (PTA). These are used in arteries with atherosclerotic lesions to compress the plaque expand the artery lumen to reopen occluded or heavily stenosed atherosclerotic lesions. Balloons are often used in combination with a stent to prop the treated vessel segment open. In addition to plain old balloon angioplasty (POBA), this section includes news about drug-coated balloon (DCB), valvuloplasty balloons and specialty cutting balloon.

Medtronic IN.PACT Admiral Drug Coated Balloon Peripheral Artery Disease Treatmen
News | October 14, 2014
October 14, 2014 — Presented for the first time at the 2014 Transcatheter Cardiovascular Therapeutics (TCT) conference...
FDA Clears Lutonix 035 Drug Coated Balloon C.R. Bard Inc.
Technology | October 13, 2014
October 13, 2014 — C. R. Bard Inc. announced the U.S. Food and Drug Administration (FDA) approval of the Lutonix 035...
Feature | September 26, 2014
September 26, 2014 — A new clinical trial comparing the use of everolimus-eluting stents (EES) and drug-eluting...
Technology | September 11, 2014
September 11, 2014 — Medtronic announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and launch of the...
Technology | August 12, 2014
August 12, 2014 — Teleflex Inc.’s subsidiary Hotspur Technologies Inc. received U.S. Food and Drug Administration (FDA...
Boston Scientific Corp. CE mark Ranger Ranger Paclitaxel-coated PTA Balloon Cath
Feature | July 28, 2014
July 28, 2014 — Boston Scientific Corp. received CE mark for the Ranger Paclitaxel-coated PTA Balloon Catheter. The...
agent, boston scientific, balloon catheter
News | July 25, 2014
July 25, 2014 -- Continuing to advance the development of innovative treatment options for coronary artery disease,...
Technology | July 11, 2014
July 11, 2014 — Cordis Corp. announced the launch of its Saber PTA (percutaneous transluminal angioplasty) dilatation...
FDA Recommendation Lutonix Drug Coated Balloon Catheter
Feature | June 16, 2014
June 16, 2014 — C. R. Bard Inc. announced that the U.S. Food and Drug Administration’s (FDA) Circulatory System Devices...
News | June 03, 2014
June 3, 2014 — Medtronic Inc. announced CE mark and launch of the NC Euphora noncompliant balloon dilatation catheter....
Feature | May 23, 2014
May 23, 2014 — The first drug-eluting balloon to go up for review by the U.S. Food and Drug Administration (FDA) will...
News | May 14, 2014
May 14, 2014 — OrbusNeich announced the launch of the Sapphire II NC coronary dilatation catheter, a non-compliant...
News | April 23, 2014
April 23, 2014 — Interim results from The Chocolate Bar Registry conducted in the United States demonstrate that use of...
IN.PACT Drug-eluting Balloon Angioplasty IN.PACT SFA Clinical Trial
News | April 16, 2014
April 16, 2014 — Patients with peripheral artery disease in the upper leg experienced significantly better outcomes at...
Drug-eluting Balloon Angioplasty Clinical Study Trial Diabetes Restenosis
News | March 06, 2014
March 6, 2014 — Despite good immediate results, in up to 40 percent of patients, obstructed arteries in the leg treated...